What is Alto Pharmacy?
Alto Pharmacy operates as a digitally native pharmacy platform designed to bridge the gap between complex medication management and patient accessibility. By integrating advanced software infrastructure with expert pharmacist oversight, the company provides a seamless, end-to-end experience that simplifies prescription fulfillment. Its market position is defined by a commitment to cost-conscious delivery, improved medication adherence, and enhanced communication channels between healthcare providers and patients. As a key player in the digital health ecosystem, Alto Pharmacy leverages its proprietary technology to optimize supply chain efficiency and improve health outcomes, effectively challenging legacy pharmacy incumbents through superior user experience and operational agility.
How much funding has Alto Pharmacy raised?
Alto Pharmacy has raised a total of $564.8M across 6 funding rounds:
Series B
$23M
Series C
$50M
Series D
$250M
Series E
$200M
Debt
$1.8M
Debt
$40M
Series B (2017): $23M with participation from Jackson Square Ventures and GREENOAKS
Series C (2018): $50M led by SoftBank Vision Fund 2
Series D (2020): $250M supported by Greenoaks, Zola Global Investors, SoftBank Group Corp, Jackson Square Ventures, and OliveTree Capital
Series E (2022): $200M featuring Softbank Vison Fund
Debt (2024): $1.8M backed by US Bank Tower
Debt (2024): $40M with participation from SoftBank Group Corp
Key Investors in Alto Pharmacy
SoftBank Group Corp
SoftBank Group Corp. is a global technology holding company that drives innovation across AI, robotics, and internet services, leveraging its massive investment platforms to scale transformative businesses.
Jackson Square Ventures
Jackson Square Ventures is a specialized investment firm focused on software and marketplace businesses, prioritizing strong business fundamentals and long-term partnerships with visionary founders.
GREENOAKS
Greenoaks is a dedicated investment partner focused on supporting exceptional founders in building generational, sustainable businesses through long-term collaboration.
What's next for Alto Pharmacy?
With the recent influx of capital, Alto Pharmacy is well-positioned to accelerate its expansion into new geographic markets and deepen its technological capabilities. The company's strategic roadmap likely involves scaling its digital infrastructure to support a larger patient base while further integrating with healthcare provider networks to streamline the prescription lifecycle. By focusing on long-term sustainability and operational excellence, Alto Pharmacy aims to solidify its role as a critical component of the modern healthcare infrastructure, potentially exploring new service lines that leverage its existing pharmacy-tech stack to address broader patient needs.
See full Alto Pharmacy company page
